Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 62016TB0117

    Kawża T-117/16: Digriet tal-Qorti Ġenerali tas-7 ta’ Marzu 2017 – Isdin vs EUIPO – Spirig Pharma (ERYFOTONA ACTINICA)

    ĠU C 144, 8.5.2017, p. 62–62 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    Date of document:
    07/03/2017
    Date lodged:
    21/03/2016
    Author:
    Il-Qorti Ġenerali
    Form:
    Informazzjoni ġudizzjarja
    Authentic language:
    Ingliż
    Type of procedure:
    Rikors għal annullament
    Link
    Select all documents mentioning this document
    Case affecting:
    Link

    8.5.2017   

    MT

    Il-Ġurnal Uffiċjali tal-Unjoni Ewropea

    C 144/62

    Digriet tal-Qorti Ġenerali tas-7 ta’ Marzu 2017 – Isdin vs EUIPO – Spirig Pharma (ERYFOTONA ACTINICA)

    (Kawża T-117/16) (1)

    (2017/C 144/92)

    Lingwa tal-kawża: l-Ingliż

    Il-President tat-Tielet Awla ordna t-tħassir tal-kawża.

    (1)  ĠU C 191, 30.5.2016.

    Top